Evaluation of the automated Vitek 2 system for detection of various mechanisms of macrolide and lincosamide resistance in Staphylococcus aureus

Journal of Clinical Microbiology

Volumn 52, Issue 11, 2014, Pages 4087-4089

  Filippin, Lorenzo ^a   Roisin, Sandrine ^a   Nonhoff, Claire ^a   Vandendriessche, Stien ^a   Heinrichs, Amélie ^a   Denis, Olivier ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; METHYLTRANSFERASE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; AUTOMATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ERM(A) GENE; ERM(B) GENE; ERM(C) GENE; ERM(T) GENE; GENE IDENTIFICATION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MSR(A) GENE; NONHUMAN; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; STAPHYLOCOCCUS AUREUS; VITEK 2; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LABORATORY AUTOMATION; MICROBIAL SENSITIVITY TEST; PHENOTYPE; PROCEDURES;

ANTI-BACTERIAL AGENTS; AUTOMATION, LABORATORY; HUMANS; LINCOSAMIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STAPHYLOCOCCUS AUREUS;

EID: 84908326810     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01617-14     Document Type: Article

References (23)

1. Weisblum B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585. http://dx.doi.org/10.1128/AAC.39.3.577.
2. Weisblum B. 1998. Macrolide resistance. Drug Resist. Updat. 1:29-41. http://dx.doi.org/10.1016/S1368-7646(98)80212-4.
3. Roberts M, Sutcliffe J, Courvalin P, Jensen L, Rood J, Seppala H. 1999.Nomenclature for macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
4. Fernandez-Munoz R, Monro RE, Torres-Pinedo R, Vazquez D. 1971.Substrate-and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites. Eur. J. Biochem. 23:185-193.
5. Eady E, Ross J, Tipper J, Walters C, Cove J, Noble W. 1993. Distributionof genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J. Antimicrob. Chemother. 31:211-217. http://dx.doi.org/10.1093/jac/31.2.211.
6. Hamilton-Miller J, Shah S. 2000. Patterns of phenotypic resistance to themacrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J. Antimicrob. Chemother. 46:941-949. http://dx.doi.org/10.1093/jac/46.6.941.
7. Yilmaz G, Aydin K, Iskender S, Caylan R, Koksal I. 2007. Detection and prevalence of inducible clindamycin resistance in staphylococci. J. Med.Microbiol. 56:342-345. http://dx.doi.org/10.1099/jmm.0.46761-0.
8. Drinkovic D, Fuller E, Shore K, Holland D, Ellis-Pegler R. 2001.Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J. Antimicrob. Chemother. 48:315-316. http://dx.doi.org/10.1093/jac/48.2.315.
9. Leclercq R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of resistance elements and their clinical implications. Clin.Infect. Dis. 34:482-492. http://dx.doi.org/10.1086/324626.
10. Steward C, Raney P, Morrell A, Williams P, McDougal L, Jevitt L, McGowan J, Tenover F. 2005. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J.Clin. Microbiol. 43:1716-1721. http://dx.doi.org/10.1128/JCM.43.4.1716-1721.2005.
11. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. CLSI document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Leclercq R, Canton R, Brown D, Giske C, Heisig P, MacGowan A, Mouton J, Nordmann P, Rodloff A, Rossolini G, Soussy C, SteinbakkM, Winstanley T, Kahlmeter G. 2013. EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect. 19:141-160. http://dx.doi.org/10.1111/j.1469-0691.2011.03703.x.
13. Vandendriessche S, Kadlec K, Schwarz S, Denis O. 2011. Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals. J. Antimicrob. Chemother. 66:2455-2459. http://dx.doi.org/10.1093/jac/dkr348.
14. Maes N, Magdalena J, Rottiers S, De Gheldre Y, Struelens M. 2002.Evaluation of a triplex PCR assay to discriminate Staphylococcus aureusfrom coagulase-negative staphylococci and determine methicillin resistance from blood cultures. J. Clin. Microbiol. 40:1514-1517. http://dx.doi.org/10.1128/JCM.40.4.1514-1517.2002.
15. Lina G, Quaglia A, Reverdy M-E, Leclercq R, Vandenesch F, Etienne J.1999. Distribution of genes encoding resistance to macrolides, lincosamides and streptogramins among staphylococci. Antimicrob. Agents Chemother. 43:1062-1066.
16. Jenssen W, Thakker-Varia S, Dubin D, Weinstein M. 1987. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob. Agents Chemother. 31:883-888. http://dx.doi.org/10.1128/AAC.31.6.883.
17. Di Modugno V, Guerrini M, Shah S, Hamilton-Miller J. 2002. Low level resistance to oleandomycin as a marker of ermA in staphylococci. J. Antimicrob. Chemother. 49:425-427. http://dx.doi.org/10.1093/jac/49.2.425.
18. Frank A, Marcinak J, Mahgat P, Tjhio J, Kelkar S, Schreckenberger P, Quinn J. 2002. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21:530-534. http://dx.doi.org/10.1097/00006454-200206000-00010.
19. Nicola F, McDougal L, Biddle J, Tenover F. 1998. Characterization of erythromycin-resistant isolates of Staphylococcus aureus recovered in the United States from 1958 through 1969. Antimicrob. Agents Chemother.42:3024-3027.
20. Buchan B, Anderson N, Ledeboer N. 2012. Comparison of BD Phoenixand bioMérieux Vitek 2 automated systems for the detection of macro-lide- lincosamide-streptogramin B resistance among clinical isolates of Staphylococcus. Diagn. Microbiol. Infect. Dis. 72:291-294. http://dx.doi.org/10.1016/j.diagmicrobio.2011.12.003.
21. Lavallée C, Rouleau D, Gaudreau C, Roger M, Tsimiklis C, Locas M-C, Gagnon S, Delorme J, Labbé A-C. 2010. Performance of an agar dilution method and a Vitek 2 card for detection of inducible clindamycin resistance in Staphylococcus spp. J. Clin. Microbiol. 48:1354-1357. http://dx.doi.org/10.1128/JCM.01751-09.
22. Gardiner B, Grayson M, Wood G. 2013. Inducible resistance to clindamycinin Staphylococcus aureus: validation of Vitek-2 against CLSI D-test. Pathology45:181-184. http://dx.doi.org/10.1097/PAT.0b013e32835cccda.
23. Bobenchik A, Hindler J, Giltner C, Saeki S, Humphries R. 2014.Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcusspp. and Enterococcus spp. J. Clin. Microbiol. 52:392-397. http://dx.doi.org/10.1128/JCM.02432-13.